Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nordic Pharma Inc AS
AS
Active
Org 989166514
Ropnesvegen 71, 9107
Kvaløya
Manufacture of oils and fats
·
NACE 1041
Est. 2006 · 20 years old
55 employees
www.noromega.no
Monitor
Share
Norway
/
Companies
/
Manufacture of oils and fats
/
Nordic Pharma Inc AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
408M
306M
204M
102M
0M
2021: 177M
177M
2021
2022: 199M (+12% vs 2021)
199M
+12%
2022
2023: 265M (+33% vs 2022)
265M
+33%
2023
2024: 289M (+9% vs 2023)
289M
+9%
2024
2025: 328M (+13% vs 2024)
328M
+13%
2025
EBITDA
NOK millions
112M
84M
56M
28M
0M
2021: 72M
72M
2021
2022: 72M (0% vs 2021)
72M
0%
2022
2023: 73M (+1% vs 2022)
73M
+1%
2023
2024: 83M (+14% vs 2023)
83M
+14%
2024
2025: 90M (+8% vs 2024)
90M
+8%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
327 727
288 844
264 923
199 015
176 563
Staff expenses
−36 670
−30 219
−28 515
−29 866
−19 834
EBITDA
89 523
83 087
73 442
72 114
71 859
Depreciation & amort.
−26 618
−25 857
−23 314
−22 135
−19 230
EBIT
62 905
57 230
50 128
49 979
52 629
Net financials
−5 954
−3 855
−16 254
−7 654
−1 821
Profit before tax
56 951
53 375
33 874
42 325
50 808
Tax
12 532
11 671
7 456
9 312
11 184
Net profit
44 420
41 704
26 418
33 013
39 624
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
521 040
503 593
460 408
455 527
419 789
Equity
374 593
330 173
288 469
262 051
229 038
Long-term debt
112 004
135 293
146 858
165 128
134 639
Short-term debt
34 444
38 128
25 081
28 348
56 113
Total debt
146 448
173 420
171 939
193 476
190 752
Financial ratios
5-year trend
EBITDA margin
27,3 %
This company
15,8 %
Market median
This company
Market median
73% above market
2021
2025
Equity ratio
71,9 %
This company
38,2 %
Market median
This company
Market median
88% above market
2021
2025
Return on equity
11,9 %
This company
18,4 %
Market median
This company
Market median
35% below market
2021
2025
Net profit margin
13,6 %
This company
8,1 %
Market median
This company
Market median
68% above market
2021
2025
Asset turnover
0,63×
This company
1,12×
Market median
This company
Market median
44% below market
2021
2025
Debt / equity
0,39×
This company
0,62×
Market median
This company
Market median
37% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Nordic Pharma Inc AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
